Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Normally I'd agree - but on 3yr paper

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
10nisman Member Profile
 
Followed By 6
Posts 1,504
Boards Moderated 0
Alias Born 10/26/03
160x600 placeholder
U.S. Stocks Rebound; Dow Flat Over Month
U.S. stocks rebounded from early losses but were range-bound on Tuesday, as investors digested mixed economic reports on housing, manufacturing and consumer confidence.
Top Equities Stories Of The Day
JAL Customer Data Target of Cyber Attack
Tibco Software to be Taken Private
Morningstar Cuts Pimco Total Return Fund Rating From Gold to Bronze
Bank Branches in U.S. Dip to Lowest Since 2005
IPO Scorecard: Update on Selected Initial Stock Offerings
Bank Branches in U.S. Decline to Lowest Level Since 2005
Starboard Pushes For Potential Yahoo-AOL Tie-Up -- 5th Update
Intel Invests in Chinese Chip Maker -- Update
10nisman   Thursday, 09/23/10 12:08:13 PM
Re: wallstarb post# 104887
Post # of 182279 
Quote:
Normally I'd agree - but on 3yr paper it doesnt have the duration for a longer term investment, and unless MSFT is buying junk bonds with it I really dont see the point for them. Perhaps an acquisition on the horizon - or maybe they are buying some CMOs

The vast majority of MSFT's cash is overseas and thus to get around paying taxes to repatriate it they chose to issue debt at insanely attractive levels. MSFT will likely use the cash to pay its dividend and buy-back shares.

10nis

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist